Merck (MRK) Change in Acquisitions & Divestments (2009 - 2026)

Merck (MRK) has reported Change in Acquisitions & Divestments for 18 consecutive years, with $1.3 billion the latest figure, recorded in Q2 2026.

• On a quarterly basis, Change in Acquisitions & Divestments rose 116.81% year-over-year to $1.3 billion in Q2 2026; TTM through Jun 2026 was $1.9 billion, a 72.71% increase from a year earlier, with the FY2025 full-year figure at $1.7 billion, up 345.09% from the prior year.
• Change in Acquisitions & Divestments was $1.3 billion for Q2 2026 at Merck, up from $46.0 million in the prior quarter.
• Over five years, Change in Acquisitions & Divestments peaked at $1.3 billion in Q2 2026 and troughed at $1.0 million in Q1 2022.
• A 5-year average of $337.5 million and a median of $285.0 million in 2023 frame the typical range for Change in Acquisitions & Divestments.
• Across the five-year window, Change in Acquisitions & Divestments slumped 99.74% in 2022 and soared 49900.0% in 2023, its largest moves.
• Over 5 years, Change in Acquisitions & Divestments stood at $12.0 million in 2022, then jumped by 1308.33% to $169.0 million in 2023, then tumbled by 95.86% to $7.0 million in 2024, then jumped by 557.14% to $46.0 million in 2025, then soared by 2732.61% to $1.3 billion in 2026.
• The last three Change in Acquisitions & Divestments figures came in at $1.3 billion (Q2 2026), $46.0 million (Q4 2025), and $575.0 million (Q3 2025), per Business Quant data.